In this webinar, Afshin Safavi, Co-Founder and Chief Scientific Officer of BioAgilytix, discusses the considerations for evaluation of accuracy, parallelism and reagent lot-to-lot variability in single and multiplex biomarker ligand binding assays.
What You'll Learn:
- How, through case studies, bioanalytical labs have overcome the key challenges of executing biomarker studies;
- The requirements for parallelism to assess the suitability of using a recombinant protein calibrator in a simple buffer matrix for measurement of a sample;
- Why and how “relative accuracy” should be considered during the assay validation, and when values are assigned to samples used for quality controls during the sample analysis;
- How to control lot-to-lot variability of critical reagents and commercial immunoassay kits, particularly for multiplex assays.
Complete the form below to access the full webinar!